Ahren Innovation Capital

Ahren is a deep tech and deep science investment firm set up by Alice Newcombe-Ellis alongside co-Founding Science Partners. Together, these Founders created companies and/or technologies that are today valued in excess of $100BN combined. The firm was established from first principles with a mission to be disruptive as an investment institution, with a new model – genuine partnership between the creators of deep technology and deep science, and commercially active, long-term capital, to harness tremendous global talent and build and exponentially accelerate the next generation of great enterprises. Ahren’s Portfolio companies include AI21 Labs, Graphcore, Zapata Computing, ZOE, Phaidra, Heirloom Carbon, and Bicycle Therapeutics among others. Ahren has >$800M AUM and has team members in Cambridge (UK), London, and Boston.

Ahren’s Founding and Science Partners:

• Alice Newcombe-Ellis (Founding & General Partner), formerly an investor at TPG Capital and Lansdowne Partners; Double First-Class degree in Mathematics and Master’s in Maths & Physics from the University of Cambridge; Fulbright and Baker Scholar at Harvard Business School.
• Sir Shankar Balasubramanian, principal inventor of the leading next generation human genome sequencing technology core to all sequencing platforms of Illumina (approximately $60BN market cap).
• Professor Andy Parker, CERN leader (founder of the ATLAS experiment for the Large Hadron Collider); Head of the Cavendish Laboratory (Physics Department), Cambridge University.
• Professor Zoubin Ghahramani, co-founder of Geometric Intelligence (sold to Uber); former Uber Chief Scientist & VP for AI; now Distinguished Scientist and Snr. Research Director at Google Brain.
• Professor John Daugman, Professor of Computer Vision and Pattern Recognition at University of Cambridge; inventor of IRIS (eye) recognition technology being used to register India’s 1.4BN citizens and build c.$3BN market.
• Professor Roberto Cipolla, Professor of Information Engineering, Cambridge University; Director of Toshiba’s Cambridge Research Laboratory; Distinguished Fellow of The British Machine Vision Association.
• Lord Martin Rees, world-renowned astrophysicist; Astronomer Royal; founder of CSER; former President of the Royal Society and former Master of Trinity College, University of Cambridge.
• Professor Steve Jackson, Head of Cancer Research UK Laboratories at the Gurdon Institute, University of Cambridge; originator of Olaparib/Lynparza, now partnered by AstraZeneca with Merck and valued up to $17BN in 2017.
• Sir Venki Ramakrishnan, 2009 Nobel laureate for atomic structure and function of the ribosome; former President of the Royal Society, the UK’s premier science body.
• Sir Gregory Winter, 2018 Nobel laureate for phage display; inventor of technology leading to Humira ($20.7BN sales in 2021, the world’s greatest grossing drug) and founder of three companies. Former Master of Trinity College, University of Cambridge.